The only gene-focused study of ACTL10 in the literature is a TCGA correlation of RNA expression and DNA methylation with survival in cytogenetically normal AML. It reports no molecular function, localisation, partner or phenotype, and its authors state that the gene is essentially unstudied. It therefore supports no GO annotation.

The study's own conclusion is explicitly prognostic rather than mechanistic, and it names mechanism as the outstanding gap.

Mouse Actl10 is testis-enriched at the tissue level and moderately expressed in spermatids, corroborating the human testis-enrichment call in an independent species and dataset.

No germline phenotype has been linked to Actl10 mutant mice. This is the authors' own statement about the state of knowledge, made while surveying the genes flanking the Wnt1-Cre2 insertion site, and it is the basis for declining to modify the GO:0007010 row to a more specific process term as the ACTL7A review did on the strength of a knock-out phenotype.

The entry contains no FUNCTION, SUBCELLULAR LOCATION or SUBUNIT comment. Its only CC line is a family-membership statement whose evidence code ECO:0000305 is curator inference rather than similarity to a named entry, and the only sequence feature is the chain itself.

The protein is nevertheless detected, so the correct statement is that no functional or biochemical characterisation exists, not that there is no data of any kind.

The gene is tissue-enriched in testis in human.

GO's curated set for this gene consists of two phylogenetic inferences and nothing else, and Pharos independently classifies the protein as a dark target.

The human genome encodes 167 uninterrupted in-frame codons immediately upstream of Q5JWF8's annotated initiator, within the single-exon MANE transcript's own 5-prime leader, and their translation is actin, including the phosphate-binding loop 1 motif absent from the annotated protein. The reading frame is proven rather than assumed, by first asserting that the annotated CDS translates to the Swiss-Prot sequence.

Twenty of the thirty-eight filament-interface positions previously scored as gaps for ACTL10 are not substitutions but positions the annotated sequence never reaches. Repaired, ACTL10 scores 11 of 38 chemically compatible, identical to ACTL8 and to Sapajus ACTL10, rather than the 5 of 18 that made it look like the most degraded actin relative in the family.

The five nucleotide-site positions the annotated sequence fails to reach are exactly actin's phosphate-binding loop 1, and the extended reading frame retains all five as four identical residues plus one conservative substitution. The nucleotide pocket is therefore preserved, not decayed, which removes any residue-decay argument for removing ACTL10's function annotation.

Within PTHR11937, GO:0005200 is asserted by IBD at the single node PTN000940351 and then negated by IRD at eight descendant nodes covering every divergent-actin clade PAINT has curated, while ten human genes still receive it from PTN000940351: four conventional muscle actins plus ACTL9, ACTL10, ACTR10 and ACTRT1-3.

ACTL10 orthologue lengths do not follow the phylogeny; in four of four sister-taxon pairs tested, two members of one mammalian family carry different annotated lengths, which is what first indicated a gene-model rather than a biological explanation.